[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Endocrine System Drug Market Report 2017

October 2017 | 95 pages | ID: U5C33508551EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Endocrine System Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Endocrine System Drug in these regions, from 2012 to 2022 (forecast).
United States Endocrine System Drug market competition by top manufacturers/players, with Endocrine System Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Novo Nordisk
  • Sanofi
  • Merck
  • Eli Lilly
  • AstraZeneca
  • AbbVie
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Diabetes Drug
  • Human Growth Hormones
  • Thyroid Hormone Disorder Drugs
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Medical Center
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Endocrine System Drug Market Report 2017

1 ENDOCRINE SYSTEM DRUG OVERVIEW

1.1 Product Overview and Scope of Endocrine System Drug
1.2 Classification of Endocrine System Drug by Product Category
  1.2.1 United States Endocrine System Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Endocrine System Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Diabetes Drug
  1.2.4 Human Growth Hormones
  1.2.5 Thyroid Hormone Disorder Drugs
  1.2.6 Others
1.3 United States Endocrine System Drug Market by Application/End Users
  1.3.1 United States Endocrine System Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Medical Center
  1.3.5 Others
1.4 United States Endocrine System Drug Market by Region
  1.4.1 United States Endocrine System Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Endocrine System Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Endocrine System Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Endocrine System Drug Status and Prospect (2012-2022)
  1.4.5 New England Endocrine System Drug Status and Prospect (2012-2022)
  1.4.6 The South Endocrine System Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Endocrine System Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Endocrine System Drug (2012-2022)
  1.5.1 United States Endocrine System Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Endocrine System Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES ENDOCRINE SYSTEM DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Endocrine System Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Endocrine System Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Endocrine System Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Endocrine System Drug Market Competitive Situation and Trends
  2.4.1 United States Endocrine System Drug Market Concentration Rate
  2.4.2 United States Endocrine System Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Endocrine System Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ENDOCRINE SYSTEM DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Endocrine System Drug Sales and Market Share by Region (2012-2017)
3.2 United States Endocrine System Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Endocrine System Drug Price by Region (2012-2017)

4 UNITED STATES ENDOCRINE SYSTEM DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Endocrine System Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Endocrine System Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Endocrine System Drug Price by Type (2012-2017)
4.4 United States Endocrine System Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ENDOCRINE SYSTEM DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Endocrine System Drug Sales and Market Share by Application (2012-2017)
5.2 United States Endocrine System Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ENDOCRINE SYSTEM DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novo Nordisk
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Endocrine System Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novo Nordisk Endocrine System Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi
  6.2.2 Endocrine System Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi Endocrine System Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.2 Endocrine System Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Endocrine System Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Eli Lilly
  6.4.2 Endocrine System Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli Lilly Endocrine System Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 AstraZeneca
  6.5.2 Endocrine System Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 AstraZeneca Endocrine System Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AbbVie
  6.6.2 Endocrine System Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AbbVie Endocrine System Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview

7 ENDOCRINE SYSTEM DRUG MANUFACTURING COST ANALYSIS

7.1 Endocrine System Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Endocrine System Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Endocrine System Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Endocrine System Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ENDOCRINE SYSTEM DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Endocrine System Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Endocrine System Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Endocrine System Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Endocrine System Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Endocrine System Drug
Figure United States Endocrine System Drug Market Size (Units) by Type (2012-2022)
Figure United States Endocrine System Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Diabetes Drug Product Picture
Figure Human Growth Hormones Product Picture
Figure Thyroid Hormone Disorder Drugs Product Picture
Figure Others Product Picture
Figure United States Endocrine System Drug Market Size (Units) by Application (2012-2022)
Figure United States Sales Market Share of Endocrine System Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Endocrine System Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Endocrine System Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Endocrine System Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Endocrine System Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Endocrine System Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Endocrine System Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Endocrine System Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Endocrine System Drug Sales (Units) and Growth Rate (2012-2022)
Figure United States Endocrine System Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Endocrine System Drug Market Major Players Product Sales Volume (Units) (2012-2017)
Table United States Endocrine System Drug Sales (Units) of Key Players/Suppliers (2012-2017)
Table United States Endocrine System Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Endocrine System Drug Sales Share by Players/Suppliers
Figure 2017 United States Endocrine System Drug Sales Share by Players/Suppliers
Figure United States Endocrine System Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Endocrine System Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Endocrine System Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Endocrine System Drug Revenue Share by Players/Suppliers
Figure 2017 United States Endocrine System Drug Revenue Share by Players/Suppliers
Table United States Market Endocrine System Drug Average Price (K USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Endocrine System Drug Average Price (K USD/Unit) of Key Players/Suppliers in 2016
Figure United States Endocrine System Drug Market Share of Top 3 Players/Suppliers
Figure United States Endocrine System Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Endocrine System Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Endocrine System Drug Product Category
Table United States Endocrine System Drug Sales (Units) by Region (2012-2017)
Table United States Endocrine System Drug Sales Share by Region (2012-2017)
Figure United States Endocrine System Drug Sales Share by Region (2012-2017)
Figure United States Endocrine System Drug Sales Market Share by Region in 2016
Table United States Endocrine System Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Endocrine System Drug Revenue Share by Region (2012-2017)
Figure United States Endocrine System Drug Revenue Market Share by Region (2012-2017)
Figure United States Endocrine System Drug Revenue Market Share by Region in 2016
Table United States Endocrine System Drug Price (K USD/Unit) by Region (2012-2017)
Table United States Endocrine System Drug Sales (Units) by Type (2012-2017)
Table United States Endocrine System Drug Sales Share by Type (2012-2017)
Figure United States Endocrine System Drug Sales Share by Type (2012-2017)
Figure United States Endocrine System Drug Sales Market Share by Type in 2016
Table United States Endocrine System Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Endocrine System Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Endocrine System Drug by Type (2012-2017)
Figure Revenue Market Share of Endocrine System Drug by Type in 2016
Table United States Endocrine System Drug Price (K USD/Unit) by Types (2012-2017)
Figure United States Endocrine System Drug Sales Growth Rate by Type (2012-2017)
Table United States Endocrine System Drug Sales (Units) by Application (2012-2017)
Table United States Endocrine System Drug Sales Market Share by Application (2012-2017)
Figure United States Endocrine System Drug Sales Market Share by Application (2012-2017)
Figure United States Endocrine System Drug Sales Market Share by Application in 2016
Table United States Endocrine System Drug Sales Growth Rate by Application (2012-2017)
Figure United States Endocrine System Drug Sales Growth Rate by Application (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Endocrine System Drug Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Endocrine System Drug Sales Growth Rate (2012-2017)
Figure Novo Nordisk Endocrine System Drug Sales Market Share in United States (2012-2017)
Figure Novo Nordisk Endocrine System Drug Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Endocrine System Drug Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Endocrine System Drug Sales Growth Rate (2012-2017)
Figure Sanofi Endocrine System Drug Sales Market Share in United States (2012-2017)
Figure Sanofi Endocrine System Drug Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Endocrine System Drug Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Merck Endocrine System Drug Sales Growth Rate (2012-2017)
Figure Merck Endocrine System Drug Sales Market Share in United States (2012-2017)
Figure Merck Endocrine System Drug Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Endocrine System Drug Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Endocrine System Drug Sales Growth Rate (2012-2017)
Figure Eli Lilly Endocrine System Drug Sales Market Share in United States (2012-2017)
Figure Eli Lilly Endocrine System Drug Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Endocrine System Drug Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Endocrine System Drug Sales Growth Rate (2012-2017)
Figure AstraZeneca Endocrine System Drug Sales Market Share in United States (2012-2017)
Figure AstraZeneca Endocrine System Drug Revenue Market Share in United States (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Endocrine System Drug Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Endocrine System Drug Sales Growth Rate (2012-2017)
Figure AbbVie Endocrine System Drug Sales Market Share in United States (2012-2017)
Figure AbbVie Endocrine System Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Endocrine System Drug
Figure Manufacturing Process Analysis of Endocrine System Drug
Figure Endocrine System Drug Industrial Chain Analysis
Table Raw Materials Sources of Endocrine System Drug Major Players/Suppliers in 2016
Table Major Buyers of Endocrine System Drug
Table Distributors/Traders List
Figure United States Endocrine System Drug Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Endocrine System Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Endocrine System Drug Price (K USD/Unit) Trend Forecast (2017-2022)
Table United States Endocrine System Drug Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Endocrine System Drug Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Endocrine System Drug Sales Volume (Units) Forecast by Type in 2022
Table United States Endocrine System Drug Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Endocrine System Drug Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Endocrine System Drug Sales Volume (Units) Forecast by Application in 2022
Table United States Endocrine System Drug Sales Volume (Units) Forecast by Region (2017-2022)
Table United States Endocrine System Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Endocrine System Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Endocrine System Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories